Hypothesis

67 Matching Annotations

Dec 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer

1
1. scibot 02 Dec 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1038/s41388-025-03343-x
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12127007/
Nov 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer

1
1. scibot 23 Nov 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1038/s41388-025-03576-w
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12559007/
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Preclinical activity of the DLL3-targeted T cell engager MK-6070 in neuroendocrine prostate cancer

1
1. scibot 01 Nov 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1535-7163.MCT-25-0453
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12554248/
Oct 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Integrated Omics and Multi-Cohort Analyses Identify an Enhancer Variant Linking Ferroptosis to Precision Therapy in Prostate Cancer

1
1. scibot 03 Oct 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.CAN-24-5018
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12485374/
Sep 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer

1
1. scibot 27 Sep 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1038/s41388-025-03576-w
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12559007/
52.53.155.43 52.53.155.43

1-s2.0-S258900422501781X-main-html.html

1
1. scibot 16 Sep 2025
  
  in Public
  
  ATCC CRL-3314
  
  DOI: 10.1016/j.isci.2025.113520
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/f995d4046e40952b58ad424165ec4ce7948925e5/1-s2.0-S258900422501781X-main-html.html
Aug 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

A PSMA-targeted Tri-specific Killer Engager enhances NK cell cytotoxicity against prostate cancer

1
1. scibot 05 Aug 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/2326-6066.CIR-24-0273
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11790377/
Jun 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

ADT increases prostate cancer cell invasion via altering AR/SALL4/SOX2-OCT4 stem cell signaling

1
1. scibot 25 Jun 2025
  
  in Public
  
  CVCL_4782
  
  DOI: 10.1007/s10565-025-10046-2
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @sonofthor
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12176959/
www.cell.com www.cell.com

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways

1
1. scibot 13 Jun 2025
  
  in Public
  
  CRL-3314
  
  DOI: 10.1007/s13042-024-02499-4
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @sjvitug
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

cell.com/cell-reports/fulltext/S2211-1247(25)00550-9
May 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells

1
1. scibot 20 May 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1535-7163.MCT-24-0716
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12046331/
www.sciencedirect.com www.sciencedirect.com

DHA suppresses hormone-sensitive and castration-resistant prostate cancer growth by decreasing de novo lipogenesis

1
1. scibot 17 May 2025
  
  in Public
  
  RRID: CVCL_4782
  
  DOI: 10.1016/j.bbalip.2025.159634
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1388198125000423
Apr 2025
52.53.155.43 52.53.155.43

rational-design-and-development-of-selective-brd7-bromodomain-inhibitors-and-their-activity-in-prostate-cancer-html.html

1
1. scibot 24 Apr 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.cell.2012.02.013
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/fbc444166f400a01dc32894063d12537e1e236f5/rational-design-and-development-of-selective-brd7-bromodomain-inhibitors-and-their-activity-in-prostate-cancer-html.html
52.53.155.43 52.53.155.43

PDF-html.html

1
1. scibot 10 Apr 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1541-7786.mcr-24-0957
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/009f5d6e39c430064ce0b832cf798a7e9caafb80/PDF-html.html
www.sciencedirect.com www.sciencedirect.com

Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer

1
1. scibot 03 Apr 2025
  
  in Public
  
  C4-2
  
  DOI: 10.1016/j.bbadis.2025.167722
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0925443925000675
www.sciencedirect.com www.sciencedirect.com

FMNL2/SRC-mediated androgen receptor translocation into the nucleus promotes enzalutamide resistance of prostate cancer

1
1. scibot 01 Apr 2025
  
  in Public
  
  ATCCCRL-3314
  
  DOI: 10.1016/j.isci.2025.112205
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004225004663
Feb 2025
aacrjournals.org aacrjournals.org

Preclinical efficacy of a PSMA-targeted actinium-225 conjugate (225Ac-macropa-pelgifatamab) - a targeted alpha therapy for prostate cancer

1
1. scibot 13 Feb 2025
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1078-0432.CCR-23-3746
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

aacrjournals.org/clincancerres/article/30/11/2531/745373/Preclinical-Efficacy-of-a-PSMA-Targeted-Actinium
Jan 2025
www.sciencedirect.com www.sciencedirect.com

Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth

1
1. scibot 14 Jan 2025
  
  in Public
  
  ATCCCRL-3314
  
  DOI: 10.1016/j.xcrm.2024.101890
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S266637912400661X
Dec 2024
www.cell.com www.cell.com

MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity

1
1. scibot 28 Dec 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.celrep.2024.115120
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

cell.com/cell-reports/abstract/S2211-1247(24)01471-2
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Preclinical Characterization of ARX517, a Site-Specific Stable PSMA-Targeted Antibody–Drug Conjugate for the Treatment of Metastatic Castration-Resistant Prostate Cancer

1
1. scibot 11 Dec 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1535-7163.MCT-23-0927
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11612621/
Nov 2024
www.sciencedirect.com www.sciencedirect.com

Spatial transcriptomics identifies RBM39 as a gene associated with Gleason score progression in prostate cancer

1
1. scibot 24 Nov 2024
  
  in Public
  
  CRL-3314
  
  DOI: 10.1016/j.isci.2024.111351
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004224025768
Sep 2024
aacrjournals.org aacrjournals.org

Squalene epoxidase metabolic dependency is a targetable vulnerability in castration-resistant prostate cancer

2
1. scibot 12 Sep 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.CAN-21-3822
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
2. scibot 12 Sep 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.CAN-21-3822
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

aacrjournals.org/cancerres/article/82/17/3032/708286/Squalene-Epoxidase-Metabolic-Dependency-Is-a
Aug 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer

1
1. scibot 28 Aug 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1021/acs.jmedchem.3c00671
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10641717/
www.biorxiv.org www.biorxiv.org

Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer

1
1. scibot 20 Aug 2024
  
  in Public
  
  C4-2
  
  DOI: 10.1101/2024.07.10.602941
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @vtello
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

biorxiv.org/content/10.1101/2024.07.10.602941v2
febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com

Assessments of prostate cancer cell functions highlight differences between a pan-PI3K/mTOR inhibitor, gedatolisib, and single-node inhibitors of the PI3K/AKT/mTOR pathway

1
1. scibot 18 Aug 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1002/1878-0261.13703
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13703
www.cell.com www.cell.com

Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis

1
1. scibot 13 Aug 2024
  
  in Public
  
  CRL-3314
  
  DOI: 10.1016/j.celrep.2024.114431
  
  Resource: (RRID:CVCL_4782)
  
  Curator: @dhovakimyan1
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

cell.com/cell-reports/fulltext/S2211-1247(24)00760-5
Apr 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis

1
1. scibot 23 Apr 2024
  
  in Public
  
  Cat#CRL-3314
  
  DOI: 10.1016/j.isci.2024.109674
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11031830/
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response

1
1. scibot 20 Apr 2024
  
  in Public
  
  RRID: CVCL_4782
  
  DOI: 10.1016/j.ebiom.2024.105129
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11052917/
aacrjournals.org aacrjournals.org

Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer that promotes metabolic plasticity

1
1. scibot 19 Apr 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.CAN-23-0555
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @anisehay
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

aacrjournals.org/cancerres/article/84/5/703/734936/Adipose-Triglyceride-Lipase-Is-a-Therapeutic
Feb 2024
52.53.155.43 52.53.155.43

can-23-0555-html.html

2
1. scibot 23 Feb 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.can-23-0555
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
2. scibot 23 Feb 2024
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.can-23-0555
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/e8db3efafb8a8253e8641e16f59e9a4a6a668dad/can-23-0555-html.html
Jan 2024
www.sciencedirect.com www.sciencedirect.com

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

1
1. scibot 20 Jan 2024
  
  in Public
  
  CRL-3314
  
  DOI: 10.1016/j.xcrm.2023.101381
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379123006109
Dec 2023
www.sciencedirect.com www.sciencedirect.com

AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing β-catenin expression

1
1. scibot 21 Dec 2023
  
  in Public
  
  ATCCCat#CRL-3314
  
  DOI: 10.1016/j.isci.2023.108523
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004223026007
Nov 2023
www.sciencedirect.com www.sciencedirect.com

PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer

2
1. scibot 28 Nov 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.chembiol.2023.10.023
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @olekpark
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
2. scibot 28 Nov 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.chembiol.2023.10.023
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945623003847
Sep 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Mechanistic target of rapamycin (mTOR) regulates self-sustained quiescence, tumor indolence, and late clinical metastasis in a Beclin-1-dependent manner

1
1. scibot 22 Sep 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1080/15384101.2022.2123187
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9928463/
Aug 2023
52.53.155.43 52.53.155.43

FEBS Press

1
1. scibot 03 Aug 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1002/1878-0261.13484
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/908848ce9212d2a4c8be94b24c71e399d1f50f03/Molecular Oncology - 2023 - Ito-html.html
Jul 2023
52.53.155.43 52.53.155.43

rational-design-and-development-of-selective-brd7-bromodomain-inhibitors-and-their-activity-in-prostate-cancer-html.html

1
1. scibot 26 Jul 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.26434/chemrxiv-2023-phgwf
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/fbc444166f400a01dc32894063d12537e1e236f5/rational-design-and-development-of-selective-brd7-bromodomain-inhibitors-and-their-activity-in-prostate-cancer-html.html
Jun 2023
www.sciencedirect.com www.sciencedirect.com

Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer

1
1. scibot 23 Jun 2023
  
  in Public
  
  CVCL_4782
  
  DOI: 10.1016/j.ccell.2023.05.016
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823001836
www.sciencedirect.com www.sciencedirect.com

Minor intron splicing is critical for survival of lethal prostate cancer

1
1. scibot 09 Jun 2023
  
  in Public
  
  RRID: CRL-3314
  
  DOI: 10.1016/j.molcel.2023.05.017
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @sofiakhan13
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1097276523003738
May 2023
www.biorxiv.org www.biorxiv.org

The androgen receptor does not directly regulate the transcription of DNA damage response genes

1
1. scibot 19 May 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1101/2023.05.13.540653
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @jmitrevska
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

biorxiv.org/content/10.1101/2023.05.13.540653v1
Mar 2023
www.nature.com www.nature.com

HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer

1
1. scibot 29 Mar 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1038/s41419-023-05742-y
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

nature.com/articles/s41419-023-05742-y
Feb 2023
aacrjournals.org aacrjournals.org

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

1
1. scibot 10 Feb 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.CAN-22-1533
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

aacrjournals.org/cancerres/article/83/2/219/715076/Plk1-Inhibitors-and-Abiraterone-Synergistically
www.science.org www.science.org

PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition

1
1. scibot 06 Feb 2023
  
  in Public
  
  RRID: CRL-3314
  
  DOI: 10.1126/sciadv.ade8641
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @bandrow
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

science.org/doi/10.1126/sciadv.ade8641
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Optimization and characterization of a bone culture model to study prostate cancer bone metastasis

1
1. scibot 04 Feb 2023
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1535-7163.MCT-21-0684
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9357208/
Aug 2022
52.53.155.43 52.53.155.43

can-21-3822-html.html

1
1. scibot 27 Aug 2022
  
  in Public
  
  RRID: CVCL_4782
  
  DOI: 10.1158/0008-5472.CAN-21-3822
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @a5munoz
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/dd3eefda3af893731a099d04e9c9cf29063e7336/can-21-3822-html.html
52.53.155.43 52.53.155.43

1360-html.html

1
1. scibot 27 Aug 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1535-7163.MCT-21-0684
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

52.53.155.43/49d342e1bd5865d528f0b694cb2824f7aad4df9f/1360-html.html
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer

1
1. scibot 26 Aug 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.7554/eLife.73396
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9398446/
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

1
1. scibot 26 Aug 2022
  
  in Public
  
  CVCL_4782
  
  DOI: 10.1158/1078-0432.CCR-22-0851
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9378683/
www.sciencedirect.com www.sciencedirect.com

Air-liquid organotypic assays to investigate cellular crosstalk in the tumor microenvironment of cancer cells

1
1. scibot 22 Aug 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.xpro.2022.101635
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666166722005159
Jul 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer

1
1. scibot 12 Jul 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1002/1878-0261.13166
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9251882/
May 2022
www.sciencedirect.com www.sciencedirect.com

The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62

1
1. scibot 11 May 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.celrep.2022.110792
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124722005599
www.cell.com www.cell.com

Systematic discovery of mutation-directed neo-protein-protein interactions in cancer

1
1. scibot 05 May 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.cell.2022.04.014
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

cell.com/cell/fulltext/S0092-8674(22)00461-5
Apr 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

MIRO2 regulates prostate cancer cell growth via GCN1-dependent stress signaling

1
1. scibot 08 Apr 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/1541-7786.MCR-21-0374
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8983529/
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer

1
1. scibot 07 Apr 2022
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.3389/fcell.2022.798590
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8979106/
Mar 2022
www.sciencedirect.com www.sciencedirect.com

Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer

1
1. scibot 18 Mar 2022
  
  in Public
  
  ATCCCRL-3314
  
  DOI: 10.1016/j.xcrm.2022.100561
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @sophiastull
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379122000684
Nov 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

AXL cooperates with EGFR to mediate neutrophil elastase-induced migration of prostate cancer cells

1
1. scibot 16 Nov 2021
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.isci.2021.103270
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8567381/
Aug 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression

1
1. scibot 17 Aug 2021
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1158/0008-5472.CAN-20-1417
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8026650/
www.sciencedirect.com www.sciencedirect.com

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer

1
1. scibot 01 Aug 2021
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.celrep.2019.10.068
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124719313828
Apr 2021
www.sciencedirect.com www.sciencedirect.com

SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways

1
1. scibot 17 Apr 2021
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.ccell.2020.05.022
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610820302725
Feb 2021
www.sciencedirect.com www.sciencedirect.com

An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors

1
1. scibot 24 Feb 2021
  
  in Public
  
  C4-2
  
  DOI: 10.1016/j.celrep.2021.108744
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782 RRIDCUR:Missing
Visit annotations in context

Tags

RRIDCUR:Missing

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124721000577
Jan 2021
www.nature.com www.nature.com

CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance

1
1. scibot 20 Jan 2021
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1038/s41598-021-81126-6
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_4782
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_4782

Annotators

scibot

URL

nature.com/articles/s41598-021-81126-6
Sep 2020
febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com

FEBS Press

1
1. scibot 16 Sep 2020
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1002/1878-0261.12706
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_4782
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_4782

Annotators

scibot

URL

febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.12706
Aug 2020
elifesciences.org elifesciences.org

AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR–CHK2 interaction and prostate cancer survival

1
1. scibot 20 Aug 2020
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.7554/eLife.51378
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782
Visit annotations in context

Tags

RRID:CVCL_4782

Annotators

scibot

URL

elifesciences.org/articles/51378
Jan 2020
www.sciencedirect.com www.sciencedirect.com

VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.cels.2019.05.009
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2405471219301905
www.sciencedirect.com www.sciencedirect.com

ROS and Oxidative Stress Are Elevated in Mitosis during Asynchronous Cell Cycle Progression and Are Exacerbated by Mitotic Arrest

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.cels.2019.01.005
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S240547121930033X
www.sciencedirect.com www.sciencedirect.com

Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:CVCL_4782
  
  DOI: 10.1016/j.ebiom.2018.12.050
  
  Resource: (ATCC Cat# CRL-3315, RRID:CVCL_4782)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_4782
  
  What is this?
  
  RRID:CVCL_4782 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_4782

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2352396418306273

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators

URL

Tags

Annotators